TipRanks
Medicenna Therapeutics Corp (MDNAF)
OTHER OTC:MDNAF
US Market
MDNAF
Medicenna Therapeutics Corp
RESEARCH TOOLSreports

Medicenna Therapeutics Corp (MDNAF) Ratios

252 Followers

Medicenna Therapeutics Corp Ratios

MDNAF's free cash flow for Q1 2027 was C$0.00. For the 2027 fiscal year, MDNAF's free cash flow was decreased by C$ and operating cash flow was C$0.00. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 23Mar 22
Liquidity Ratios
Current Ratio
 1.25 1.52 6.35 9.57 8.92
Quick Ratio
 1.25 1.52 6.35 9.57 8.92
Cash Ratio
 0.88 1.14 5.60 8.84 7.83
Solvency Ratio
 -2.81 -3.07 -1.27 0.22 -8.63
Operating Cash Flow Ratio
 -2.90 -3.28 -3.72 -3.33 -9.00
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
C$ 1.55MC$ 2.35MC$ 18.88MC$ 29.43MC$ 20.77M
Leverage Ratios
Debt-to-Assets Ratio
 0.01 0.01 <0.01 0.00 0.00
Debt-to-Equity Ratio
 0.06 0.05 <0.01 0.00 0.00
Debt-to-Capital Ratio
 0.06 0.05 <0.01 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 4.93 3.41 1.49 1.24 1.13
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 -327.65
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 -323.19
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 <0.01 <0.01 <0.01 0.00 <0.01
Net Debt to EBITDA
 0.24 0.26 1.90 2.06 0.91
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
93.49%93.44%90.60%-15.40%100.31%
EBT Per EBIT
83.95%83.10%60.24%46.43%101.24%
Return on Assets (ROA)
-225.03%-217.75%-41.59%4.24%-96.55%
Return on Equity (ROE)
-360.29%-741.70%-61.82%5.25%-108.69%
Return on Capital Employed (ROCE)
-1344.63%-793.24%-90.33%-66.30%-107.03%
Return on Invested Capital (ROIC)
-1208.30%-725.41%-81.67%10.21%-107.03%
Return on Tangible Assets
-226.27%-218.97%-41.67%4.25%-96.82%
Earnings Yield
-52.90%-34.58%-15.71%2.72%-25.28%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 0.01 0.02 0.02 <0.01 0.02
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 -31.24K -22.98K -17.92K -118.04K -16.06K
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 31.24K 22.98K 17.92K 118.04K 16.06K
Operating Cycle
 0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.22 -0.22 -0.22 -0.20 -0.43
Free Cash Flow Per Share
 -0.17 0.00 -0.22 -0.20 -0.43
CapEx Per Share
 0.11 0.22 <0.01 0.00 0.00
Free Cash Flow to Operating Cash Flow
 0.76 0.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -1.99 -1.00 -499.76 0.00 0.00
Capital Expenditure Coverage Ratio
 -1.99 -1.00 -499.76 0.00 0.00
Operating Cash Flow Coverage Ratio
 -180.84 -150.61 -98.17 0.00 0.00
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-45.59%0.00%-21.99%-22.22%-26.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.84 -2.91 -6.53 36.82 -3.96
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 20.97 21.45 3.93 1.93 4.30
Price-to-Free Cash Flow (P/FCF) Ratio
 -2.19 0.00 -4.55 -4.50 -3.80
Price-to-Operating Cash Flow Ratio
 -1.87 -2.97 -4.56 -4.50 -3.80
Price-to-Earnings Growth (PEG) Ratio
 0.05 -0.06 0.11 -0.35 -0.20
Price-to-Fair Value
 20.97 21.45 3.93 1.93 4.30
Enterprise Value Multiple
 -1.12 -1.99 -3.89 -1.43 -3.06
Enterprise Value
 25.85M 47.11M 50.47M 23.37M 69.04M
EV to EBITDA
 -1.12 -1.99 -3.89 -1.43 -3.06
EV to Sales
 0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 -1.80 0.00 -3.05 -1.85 -2.93
EV to Operating Cash Flow
 -1.37 -2.63 -3.06 -1.85 -2.93
Tangible Book Value Per Share
 0.02 0.03 0.25 0.45 0.38
Shareholders’ Equity Per Share
 0.02 0.03 0.25 0.46 0.38
Tax and Other Ratios
Effective Tax Rate
 0.07 0.07 0.09 1.15 >-0.01
Revenue Per Share
 0.00 0.00 0.00 0.00 0.00
Net Income Per Share
 -0.21 -0.22 -0.15 0.02 -0.42
Tax Burden
 0.93 0.93 0.91 -0.15 1.00
Interest Burden
 0.86 0.83 1.00 0.62 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.01 0.97 1.40 1.26 1.04
Currency in CAD